new-kit-box new-kit-box new-kit-box

Bright, Long-Lasting Luciferase Reagent for HiBiT PsVLPs

  • Measure intracellular luminescence in living cells
  • Optimized for elimination of extracellular background luminescence
  • Simple add-mix-read protocol for rapid results

VLP Luciferase Assay Systems

  Catalog No. Product Name   Size Price Qty  
JB1201 Bio-Glo-NB™ VLP Luciferase Assay System View Specifications 25ml List Price: $ 600.00 Your price: Add to Cart
JB1202 Bio-Glo-NB™ VLP Luciferase Assay System View Specifications 100ml List Price: $ 2,040.00 Your price: Add to Cart
JB1203 Bio-Glo-NB™ VLP Luciferase Assay System View Specifications 10 × 100ml List Price: $ 17,340.00 Your price: Add to Cart

Early Access = This product is available under our Early Access program - Learn More

Catalog (FT) = This product is available under our Catalog (FT) program - Learn More

Overview
Protocols
Specifications
Resources
Related Products

Bio-Glo-NB™ VLP Luciferase System Assay Principle

The Bio-Glo-NB™ VLP Luciferase Assay Systems are functionally tested for performance using HiBiT-PsVLP Bioassays and intended for use with those products. When pseudotyped, HiBiT-tagged VLPs are added to target cells expressing the relevant receptors, and the presence of inhibitors or neutralizing antibodies (nAbs) prevents the entry/fusion process of the PsVLPs, resulting in HiBiT not being released intracellularly, and no luminescent signal is produced. In the absence of inhibition, the HiBiT-PsVLPs bind to the target cells and undergo membrane fusion. HiBiT is released into the target cells to bind LgBiT and generate a luminescent signal.

Bio-Glo-NB™ VLP Luciferase Assay System assay principle.

Standardized Reagents to Improve Your Results

Assay Workflow

The Bio-Glo-NB™ VLP Luciferase Assay is a nonlytic detection system designed to measure intracellular NanoBiT® complementation and luminescence in living cells. This system is intended for use with our quantitative mechanism-of-action (MoA)-based Reporter Bioassays. The cell impermeable Bio-Glo-NB™ DrkBiT peptide is pre-incubated with cells to prohibit extracellular NanoBiT® complementation and eliminate extracellular background. The Bio-Glo-NB™ Live-Cell Reagent contains the cell permeable substrate, furimazine, and a proprietary agent for reducing autoluminescence and decreasing assay background.

Bio-Glo-NB™ VLP Luciferase Assay System assay workflow.

Simple Add-Mix-Read Protocol

Depiction of the Bio-Glo-NB™ VLP Luciferase Assay protocol workflow.

Specifications

Catalog Number:

Contenido

Item Part # Presentación

Bio-Glo-NB™ Live-Cell Luciferase Assay Substrate

JB120B 1 × 1.25ml

Bio-Glo-NB™ Live-Cell Luciferase Assay Buffer

JB121B 1 × 25ml

Bio-Glo-NB™ DrkBiT

JB220A 1 × 30μl

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Condiciones de Almacenaje

BB

Contenido

Item Part # Presentación

Bio-Glo-NB™ Live-Cell Luciferase Assay Substrate

JB120B 4 × 1.25ml

Bio-Glo-NB™ Live-Cell Luciferase Assay Buffer

JB121C 2 × 50ml

Bio-Glo-NB™ DrkBiT

JB220A 5 × 30μl

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Condiciones de Almacenaje

BB

Contenido

Item Part # Presentación

Bio-Glo-NB™ Live-Cell Luciferase Assay Substrate

JB120B 40 × 1.25ml

Bio-Glo-NB™ Live-Cell Luciferase Assay Buffer

JB121C 20 × 50ml

Bio-Glo-NB™ DrkBiT

JB220A 50 × 30μl

Certificado de Análisis

Search by lot number

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Condiciones de Almacenaje

BB

Resources

HiBiT-PsVLPs enable safe, rapid and quantitative assessment of virus neutralization and antibody-dependent enhancement. Non-replicating PsVLPs are suitable for BSL1/2 environments; assay run times are ≤1 day and provide a quantitative luminescence readout.

  • HiBiT-PsVLPs enable safe, rapid and quantitative assessment of virus neutralization and antibody-dependent enhancement.
  • Flexible HiBiT-PsVLP platform is compatible with diverse viruses.
  • HiBiT-PsVLP bioassays are broadly applicable across therapeutic modalities and vaccines
Read the poster
ps593-web-graphic1